A2B5 cells from human glioblastoma have cancer stem cell properties.
about
Impairment of glioma stem cell survival and growth by a novel inhibitor for Survivin-Ran protein complexIncreased Oxidative Stress as a Selective Anticancer TherapyTwisted tango: brain tumor neurovascular interactionsBrain tumor stem cells: Molecular characteristics and their impact on therapyGlioblastoma Stem-Like Cells: Characteristics, Microenvironment, and TherapyChemotherapy targeting cancer stem cellsPolysialic acid neural cell adhesion molecule (PSA-NCAM) is an adverse prognosis factor in glioblastoma, and regulates olig2 expression in glioma cell lines.A peptide derived from apoptin inhibits glioma growth.Differential analysis of glioblastoma multiforme proteome by a 2D-DIGE approach.Potential therapeutic implications of cancer stem cells in glioblastomaGlioma-associated antigen HEATR1 induces functional cytotoxic T lymphocytes in patients with glioma.Clinically relevant doses of chemotherapy agents reversibly block formation of glioblastoma neurospheres.Wnt activation is implicated in glioblastoma radioresistance.Brain tumor cells in circulation are enriched for mesenchymal gene expressionIonizing radiations sustain glioblastoma cell dedifferentiation to a stem-like phenotype through survivin: possible involvement in radioresistance.Glial progenitors as targets for transformation in glioma.Proscillaridin A is cytotoxic for glioblastoma cell lines and controls tumor xenograft growth in vivo.Evidence for label-retaining tumour-initiating cells in human glioblastomaSerological identification of URGCP as a potential biomarker for glioma.End-binding 1 protein overexpression correlates with glioblastoma progression and sensitizes to Vinca-alkaloids in vitro and in vivo.Biological characteristics of a new human glioma cell line transformed into A2B5(+) stem cells.CD133 Expression Is Not Synonymous to Immunoreactivity for AC133 and Fluctuates throughout the Cell Cycle in Glioma Stem-Like CellsMembrane glycolipids in stem cells.Dynamic epigenetic regulation of glioblastoma tumorigenicity through LSD1 modulation of MYC expression.Curcumin decreases malignant characteristics of glioblastoma stem cells via induction of reactive oxygen species.Aggressive invasion is observed in CD133(-)/A2B5(+) glioma-initiating cells.Isolation and characteristics of CD133‑/A2B5+ and CD133‑/A2B5‑ cells from the SHG139s cell line.Molecular heterogeneity of glioblastomas: does location matter?Strategies for isolating and enriching cancer stem cells: well begun is half doneEssential gene pathways for glioblastoma stem cells: clinical implications for prevention of tumor recurrence.Inhibitor of apoptosis protein expression in glioblastomas and their in vitro and in vivo targeting by SMAC mimetic GDC-0152NG2-cells are not the cell of origin for murine neurofibromatosis-1 (Nf1) optic glioma.Cancer stem cells: cell culture, markers, and targets for new therapies.Coordination of signalling networks and tumorigenic properties by ABL in glioblastoma cells.Targeted Nanotechnology in Glioblastoma Multiforme.Tumor-derived spheroids: Relevance to cancer stem cells and clinical applicationsBrain tumor stem cells: the cancer stem cell hypothesis writ large.Stem cell glycolipids.Cancer stem cells in glioblastoma--molecular signaling and therapeutic targeting.High-performance separation techniques hyphenated to mass spectrometry for ganglioside analysis.
P2860
Q24306474-A9719BC0-889A-4BBA-A856-97D86A999796Q26798210-56072FAA-489D-4C2C-BAAE-E0C07F3CBF20Q26849613-7B064FBD-574C-4154-BB8B-0C7432B5B311Q27003138-884A7D90-31D6-4601-9271-C61718AF75F6Q28079663-F2361CD2-4B57-4D64-A607-D58D302BE5B7Q28085377-3D03FF11-0BA4-4729-8CFD-4CE626ED4E62Q33539425-66F9C82A-D8EF-4D86-8726-A0B6135C8982Q33761660-4BF2CCE9-4F99-48A5-8AA0-8F07CF515FE3Q33864238-3CEF838D-3535-47B8-A281-9CA0A0E7E8ACQ33965491-4B0E265C-765B-4C86-A483-A4221FD8574FQ33999299-BBEE560D-078C-4ADA-95E7-4A7F0BE44D97Q34037067-563BB0CD-4C14-4B58-9FE5-E1ECF2CEA6B6Q34232635-6D773C2C-C1B1-49D7-A36C-FA09F29ED766Q34458631-CCBEF0DB-8425-4204-B5EB-7E444963C7DEQ34662363-3B1F645C-FA22-4B98-9E4C-72C89F627D31Q34735661-B2C49A1B-35AE-41E3-B1DC-704C31602158Q34786609-CA247D7F-5BD5-4856-8852-6884707EA129Q34992194-2448E27F-BA09-4C57-8669-C3A8014E46FDQ35059607-5CAC7CE3-00EF-470F-851B-D79B37CF77F4Q35149672-5699B22D-227F-470B-A12F-B825FE862392Q35354646-94437E08-A71D-44F0-B24D-12C5E80CB3FEQ35666904-F6C9692D-3C9B-4ADE-8A19-2B79E897AA87Q35781932-C28C8B90-E350-4273-9B44-7D1DB047D5DCQ35910268-8DED2A7D-057A-406F-A017-BBA6E0D5DA29Q36270652-2AD7F842-9BF5-4C31-99E5-1CD52411B128Q36336049-90D98E24-B618-4CCD-94A4-A0E284EFE5DCQ36592530-F8C9CFB4-1149-4062-9CC5-C51EC837653CQ36729562-F2A81FCF-8F1F-438C-AEA5-1C34CAA451A0Q37061915-F3CA8A49-321C-4658-865C-C0B06230AC0CQ37132697-8674463E-0BC9-4E60-A4E8-98DFBA630113Q37412477-F0D67D53-87FD-4771-9C23-AEC2523D93D9Q37417578-56D4C663-5FB8-44AE-9BA1-0061CE12807DQ37598736-102E77AA-AD16-460D-863C-AB64F5826729Q37688839-BC0E618E-A846-485E-84BD-5053B586DC4BQ37730943-18CC4A91-CF4D-429A-B101-AA0FF69B8A97Q37735627-01FD68A1-E982-4E32-8869-F5A59B9369E3Q37783774-B8FDCFC0-DD83-4E44-8540-A0EBE6BBB627Q37821360-E9AE7323-91D9-4D9F-A0D2-71E04AA293D1Q37825821-58F95E69-438D-4901-A7FE-C7BC8DEA3410Q37878442-DBFA18DE-23BD-44A1-B2A1-D70C1EFD7308
P2860
A2B5 cells from human glioblastoma have cancer stem cell properties.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
A2B5 cells from human glioblastoma have cancer stem cell properties.
@en
A2B5 cells from human glioblastoma have cancer stem cell properties.
@nl
type
label
A2B5 cells from human glioblastoma have cancer stem cell properties.
@en
A2B5 cells from human glioblastoma have cancer stem cell properties.
@nl
prefLabel
A2B5 cells from human glioblastoma have cancer stem cell properties.
@en
A2B5 cells from human glioblastoma have cancer stem cell properties.
@nl
P2093
P50
P1433
P1476
A2B5 cells from human glioblastoma have cancer stem cell properties.
@en
P2093
Carole Colin
Christophe Beclin
Myriam Cayre
Nathalie Baeza
Philippe Metellus
P304
P356
10.1111/J.1750-3639.2009.00269.X
P577
2009-02-20T00:00:00Z